SERPINA1 and COVID-19: Protease–antiprotease imbalances can arise during the clinical course of COVID-19 infection and recent studies have demonstrated that AAT can bind and inhibit key proteases involved in the pathophysiology of COVID-19, including TMPRSS2 [73,74] and ADAM17 [160] (Table 3).